Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
Finally, ProShare Advisors LLC bought a new stake in shares of Ardelyx in the 4th quarter valued at about $44,000.
HC Wainwright raised their price target on Ardelyx from $9.00 to $11.00 and gave the company a “buy” rating in a research note on Wednesday, November 1st.
IBSRELA is providing clinically meaningful benefits to patients and Ardelyx is establishing itself as a commercial company.
IFP Advisors Inc bought a new stake in Ardelyx during the 4th quarter valued at approximately $40,000.
If that happens, Ardelyx won’t be a penny stock for long.
Source: https://investorplace.com/market360/2023/03/7-core-stocks-to-buy-to-build-a-solid-portfolio-around/
Prosight Management LP purchased a new position in shares of Ardelyx during the 2nd quarter worth approximately $1,276,000.
Source: https://www.etfdailynews.com/2023/01/13/ardelyx-nasdaqardx-stock-price-up-4-4/